I-Corps: Non-invasive ventilation treatment for COPD patients
I-Corps: Non-invasive ventilation treatment for COPD patients
批准号:
1822281
负责人:
Jacob Brenner
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2018-09-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this I-Corps is a novel noninvasive ventilation modality for treatment of mild and severe chronic obstructive pulmonary disease (COPD) patients. Two million Americans have such severe COPD that, even on maximal medical therapy, they are unable to walk up a single flight of stairs due to severe shortness of breath. As the disease progresses, patients become bound to their house, their chair, and finally their bed. This technology provides a non-intrusive pulmonary support to patients in a form of a lightweight, mobile, and noninvasive ventilator, which can help support these patients during physical activity and help them live a full life again, free of suffocation. Long term impacts of this technology include: (1) increased quality of life and treatment effectiveness for severe COPD patients; (2) development of novel pulmonary rehabilitation therapies; (3) expansion of noninvasive ventilation technology in the field of pulmonary care to supplement and enhance current ventilation techniques.This I-Corps project is a mobile, non-invasive ventilation technology targeted at COPD patients. The device works by supplementing patient's breathing with pressure changes on their chest and abdomen. With each breath in, the device generates a vacuum that helps lift the chest and abdomen, helping the patient breathe in. With each breath out, the device increases pressure over the chest and helps the patient breath out faster. By assisting the work of breathing, patients no longer feel short of breath and can once again engage in normal daily activities. The device promotes a healthy breathing cycle, which prevents hyperinflation of the airways and degeneration of alveoli in the lungs. Noninvasive ventilation and pulmonary rehabilitation have both been shown to have significant, positive effects on the quality of life and medical outcomes of COPD patients. The technology aims to improve patient's well-being.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Non-CG DNA甲基化平衡大豆产量和SMV抗性的分子机制
-
批准号:32301796
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:寻红卫
-
依托单位:
long non-coding RNA(lncRNA)-activatedby TGF-β(lncRNA-ATB)通过成纤维细胞影响糖尿病创面愈合的机制研究
-
批准号:LQ23H150003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:厉怡
-
依托单位:
染色体不稳定性调控肺癌non-shedding状态及其生物学意义探索研究
-
批准号:82303936
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:张嘉涛
-
依托单位:
变分法在双临界Hénon方程和障碍系统中的应用
-
批准号:12301258
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:王聪
-
依托单位:
BTK抑制剂下调IL-17分泌增强CD20mb对Non-GCB型弥漫大B细胞淋巴瘤敏感性
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:李庆山
-
依托单位:
Non-TAL效应子NUDX4通过Nudix水解酶活性调控水稻白叶枯病菌致病性的分子机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郭宝佃
-
依托单位:
一种新non-Gal抗原CYP3A29的鉴定及其在猪-猕猴异种肾移植体液排斥反应中的作用
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:王毅
-
依托单位:
非经典BAF(non-canonical BAF,ncBAF)复合物在小鼠胚胎干细胞中功能及其分子机理的研究
-
批准号:32170797
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张文胜
-
依托单位:
Non-Oberbeck-Boussinesq效应下两相自然对流问题的建模及高效算法研究
-
批准号:12101391
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:潘晓敏
-
依托单位:
植物胚乳发育过程中non-CG甲基化调控的分子机制探究
-
批准号:LQ21C060001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:方慧慧
-
依托单位: